EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Postprandial Glucagon Action in the Human Brain

Robert Wagner, Stephanie Kullmann, Julia Hummel, Katsiaryna Prystupa, Elena Hosenfeld, Ralf Veit, Andreas L Birkenfeld iD, Hans-Ulrich Häring, Hubert Preissl, Andreas Fritsche, Andreas Peter, Martin Heni iD

Diabetes, Obesity and Metabolism · 2026-07 · 28 (7) · 5926-5938

DOI: 10.1111/dom.70801 ↗

At a glance

Journal article in Diabetes, Obesity and Metabolism, published online on 2026-04-22. Written by Robert Wagner and 11 co-authors. Institution: Institute for Clinical Diabetology, German Diabetes Center, Leibnitz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf…. Major MEDLINE topics: Glucagon, Postprandial Period, Brain. 54 references. The full text is freely available (open access, CC BY 4.0). Funded by: Bundesministerium für Bildung und Forschung, Bundesministerium für Forschung, Technologie und Raumfahrt.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Aims

Elevated fasting glucagon is linked to hyperglycemia, but postprandial glucagon effects are less understood. Recent evidence suggests metabolic benefits of rising glucagon after oral glucose intake, potentially impacting brain‐mediated whole‐body metabolism. To elucidate the translational relevance of these findings, we studied postprandial effects of glucagon on the human brain. Materials and Methods We performed oral glucose tolerance tests (OGTT) combined with functional magnetic resonance imaging to quantify brain activity and connectivity at fasting, 30 and 120 min post glucose load in 30 volunteers. In 14 participants with suppressed glucagon, low‐dose glucagon infusion mimicked non‐suppressed glucagon after OGTT. This was compared to 7 participants with endogenous rising glucagon during OGTT.

Results

Low‐dose glucagon infusion did not elevate plasma glucose levels during OGTT. Also, no changes in insulin sensitivity and insulin secretion were observed. However, experimentally elevating glucagon during OGTT in individuals with physiological suppression of glucagon significantly increased postprandial brain responsivity in the hippocampal gyrus and in brain regions important for the homeostatic and hedonic regulation of food intake as well as systemic metabolism (i.e., hypothalamus and ventral striatum). Most postprandial brain responsiveness during glucagon infusion was directionally consistent with the findings in persons with endogenously rising glucagon. Moreover, the postprandial brain response correlated with the rise in glucagon, regardless of exogenous or endogenous source of glucagon. Although the overall glucagon trajectory during OGTT was not significantly different over the full 0–150 min period, the groups differed at key post‐challenge timepoints and in integrated glucagon exposure. Together with the infusion and correlation analyses, this supports a relationship between postprandial glucagon and brain responsivity, while more subtle differences in glucagon kinetics will require larger studies.

Conclusions

Our findings demonstrate postprandial effects of glucagon in metabolically relevant human brain areas. This may underlie the promising effects on body weight achieved with pharmacological multi‐agonists that activate the glucagon receptor.

Subjects

MeSH terms (MEDLINE)

GlucagonPostprandial PeriodBrainHumansMaleFemaleAdultMagnetic Resonance ImagingGlucose Tolerance TestBlood GlucoseYoung AdultInsulinInsulin Resistance

Author keywords

MRI neuroimagingOGTT (oral glucose tolerance test)brain metabolismcerebral blood flowglucagonhypothalamusinsulin sensitivitymetabolic regulation

Substances

GlucagonBlood GlucoseInsulin

Authors and institutions

  • Institute for Clinical Diabetology, German Diabetes Center, Leibnitz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.
  • Department of Endocrinology and Diabetology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
  • Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Division of Endocrinology and Diabetology, Department of Internal Medicine I, University of Ulm, Ulm, Germany.

ORCID profiles: Andreas L Birkenfeld, Martin Heni

Funding

  • Bundesministerium für Bildung und Forschung
  • Bundesministerium für Forschung, Technologie und Raumfahrt

Cite

APA

Wagner, R., Kullmann, S., Hummel, J., Prystupa, K., Hosenfeld, E., Veit, R., Birkenfeld, A. L., Häring, H. U., Preissl, H., Fritsche, A., Peter, A., & Heni, M. (2026). Postprandial Glucagon Action in the Human Brain. Diabetes, Obesity and Metabolism, 28(7), 5926-5938. https://doi.org/10.1111/dom.70801

Vancouver

Wagner R, Kullmann S, Hummel J, Prystupa K, Hosenfeld E, Veit R, et al. Postprandial Glucagon Action in the Human Brain. Diabetes, Obesity and Metabolism. 2026;28(7):5926-5938. doi:10.1111/dom.70801

BibTeX
@article{Wagner2026,
  author = {Wagner, Robert and Kullmann, Stephanie and Hummel, Julia and Prystupa, Katsiaryna and Hosenfeld, Elena and Veit, Ralf and Birkenfeld, Andreas L and Häring, Hans-Ulrich and Preissl, Hubert and Fritsche, Andreas and Peter, Andreas and Heni, Martin},
  title = {Postprandial Glucagon Action in the Human Brain},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {7},
  pages = {5926--5938},
  doi = {10.1111/dom.70801}
}
Start for free →